AI Usage at a Glance
Timeline
Nov 28, 2017
Data AnalysisPractice documented: Hologic offers Quantra breast density assessment software, a machine learning tool that automatically analyzes mammography images and assigns patients to one of four breast density categories, reducing reliance on subjective visual assessment by radiologists. Version 2.2 received FDA 510(k) clearance in November 2017.
Practice DocumentedView practice →Nov 13, 2019
ProductivityPractice documented: Hologic deployed 3DQuorum Imaging Technology, an AI-powered tool that condenses large 3D mammography image sets into a smaller, more manageable set of 'SmartSlices' to reduce the time radiologists spend reading each exam. The technology received FDA approval in November 2019 and launched commercially in Europe in October 2020.
Practice DocumentedView practice →Oct 26, 2020
ProductivityNew evidence: Hologic Launches 3DQuorum™ Imaging Technology, Powered by Genius AI™, in Europe
Evidence AddedView practice →Dec 1, 2020
Data AnalysisPractice documented: Hologic deployed Genius AI Detection, a deep learning software that analyzes 3D mammography images and flags areas suspicious for breast cancer for radiologist review. The software received FDA clearance in December 2020 and is used with Hologic's 3D Mammography systems.
Practice DocumentedView practice →Jan 1, 2024
Data AnalysisPractice documented: Hologic deployed the Genius Digital Diagnostics System, combining AI with digital imaging to help cytologists and pathologists screen ThinPrep Pap test slides for cervical cancer and pre-cancerous cells. The system received FDA clearance in February 2024, making it the first and only FDA-cleared digital cytology system of its kind.
Practice DocumentedView practice →Jan 1, 2024
Data AnalysisNew evidence: Quantra® 2.2 | Breast Density Assessment Software | Hologic
Evidence AddedView practice →Jan 1, 2024
Data AnalysisNew evidence: Genius AI® Detection | Mammography AI Software | Hologic
Evidence AddedView practice →Jan 1, 2024
ProductivityNew evidence: 3DQuorum® Imaging Technology | HiRes 3D Mammography Software | Hologic
Evidence AddedView practice →Feb 1, 2024
Data AnalysisNew evidence: Hologic Announces First and Only FDA-Cleared Digital Cytology System – Genius™ Digital Diagnostics System
Evidence AddedView practice →Feb 1, 2024
Data AnalysisNew evidence: FDA De Novo Authorization – Genius Digital Diagnostics System with Genius Cervical AI Algorithm
Evidence AddedView practice →Jan 1, 2025
Data AnalysisPractice documented: Hologic offers Genius AI Detection PRO, a next-generation breast imaging AI solution that analyzes both current and prior mammogram exams, auto-generates pre-populated exam reports, and provides color-coded case scoring to help radiologists work more efficiently. The product was introduced at RSNA in December 2024 and received a MedTech Breakthrough Award in May 2025.
Practice DocumentedView practice →Apr 24, 2025
Data AnalysisNew evidence: Groundbreaking New Data on Hologic's AI-Powered Mammography Technology to Be Presented at SBI
Evidence AddedView practice →May 8, 2025
Data AnalysisNew evidence: Hologic's AI-Driven Breast Cancer Screening Technology Earns MedTech Breakthrough Award
Evidence AddedView practice →Dec 16, 2025
Data AnalysisNew evidence: Hologic's AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening Exams
Evidence AddedView practice →Recent activity
Hologic deployed 3DQuorum Imaging Technology, an AI-powered tool that condenses large 3D mammography image sets into a smaller, more manageable set of 'SmartSlices' to reduce the time radiologists spend reading each exam. The technology received FDA approval in November 2019 and launched commercially in Europe in October 2020.
3DQuorum uses Genius AI-powered analytics to reconstruct high-resolution 3D mammography data, reducing the total number of images a radiologist must review by two-thirds. The AI identifies clinically relevant regions of interest and preserves important features during reconstruction into 6mm SmartSlices. According to Hologic, the technology saves radiologists an average of one hour per eight hours of daily image interpretation time, without compromising image quality, sensitivity, or accuracy.
Hologic deployed Genius AI Detection, a deep learning software that analyzes 3D mammography images and flags areas suspicious for breast cancer for radiologist review. The software received FDA clearance in December 2020 and is used with Hologic's 3D Mammography systems.
Genius AI Detection is a deep learning algorithm trained on large databases of mammograms that searches each slice of a digital breast tomosynthesis (3D mammography) image set, highlights suspicious lesions at radiologists' workstations, and assigns a case-level priority score. The software is the only deep learning product in this category that runs directly on the mammography system's acquisition workstation without a separate server. Studies showed the software improved reader sensitivity for cancer cases by 9% and correctly flagged approximately 90% of previously identified cancer cases.
Hologic offers Quantra breast density assessment software, a machine learning tool that automatically analyzes mammography images and assigns patients to one of four breast density categories, reducing reliance on subjective visual assessment by radiologists. Version 2.2 received FDA 510(k) clearance in November 2017.
Quantra software uses a machine learning algorithm to analyze both 2D and 3D tomosynthesis mammography images for the distribution and texture of breast tissue, then classifies each patient's breast density into one of four categories aligned with American College of Radiology BI-RADS standards. The software runs directly on Hologic's 3Dimensions and Selenia Dimensions mammography system acquisition workstations, eliminating the need for a separate server. Results are displayed at the point of care and can serve as automatic input for downstream breast cancer risk assessment models.
All practices by category
Hologic deployed Genius AI Detection, a deep learning software that analyzes 3D mammography images and flags areas suspicious for breast cancer for radiologist review. The software received FDA clearance in December 2020 and is used with Hologic's 3D Mammography systems.
Hologic offers Quantra breast density assessment software, a machine learning tool that automatically analyzes mammography images and assigns patients to one of four breast density categories, reducing reliance on subjective visual assessment by radiologists. Version 2.2 received FDA 510(k) clearance in November 2017.
Hologic offers Genius AI Detection PRO, a next-generation breast imaging AI solution that analyzes both current and prior mammogram exams, auto-generates pre-populated exam reports, and provides color-coded case scoring to help radiologists work more efficiently. The product was introduced at RSNA in December 2024 and received a MedTech Breakthrough Award in May 2025.
Hologic deployed the Genius Digital Diagnostics System, combining AI with digital imaging to help cytologists and pathologists screen ThinPrep Pap test slides for cervical cancer and pre-cancerous cells. The system received FDA clearance in February 2024, making it the first and only FDA-cleared digital cytology system of its kind.
Cite this record
Trace Foundation. (2026). Hologic: documented AI practices (data as of 2026-07-09) [Data set record]. AI Trace. https://www.aitrace.org/r/company/2dccef14-eda6-4426-b442-02ae17d26fc1. Accessed October 4, 2026.
- Stable link
- https://www.aitrace.org/r/company/2dccef14-eda6-4426-b442-02ae17d26fc1
- Data as of
- July 9, 2026
- Last verified
- Not recorded
Related Companies
Mass General Brigham
MEDVi
Boston Scientific
OpenAI
Casio
Have evidence about Hologic's AI practices? Submit a report.
Submit a report →AI Trace is free and nonprofit. Support our work